Dark Mode
HPV Vaccination Global Impact Projections
Patient Health Records & Digital Health
Tags and Keywords
Trusted By
"No reviews yet"
Free
About
The projected global impact of Human Papillomavirus (HPV) vaccination efforts, specifically regarding the prevention of cervical cancer cases and related deaths. The dataset contrasts the outcomes achieved under current vaccine coverage levels against potential outcomes if the World Health Organisation’s (WHO) 90% coverage rate goal, necessary for elimination, were met. It includes key modelling results, allowing users to assess the economic viability and effectiveness of scaling up cheap, single-dose HPV vaccines to prevent millions of deaths. The underlying analysis draws on inputs from global health organisations and academic modelling interfaces.
Columns
The dataset features eleven columns providing detailed information on vaccination cohorts, coverage rates, and projected outcomes, utilizing current and future (90% target) assumptions.
- country: The specific country code.
- country_name: The full name of the country (176 unique values).
- region: The geographical region (e.g., Europe & Central Asia, Sub-Saharan Africa).
- income_group: The country’s income classification (e.g., Lower middle income, High income).
- year: The modelled year, spanning from 2021 to 2030.
- cohort_size: The total number of girls within the cohort eligible for vaccination.
- coverage: The recorded vaccination coverage rate.
- by age 15, first dose / by age 15, last dose: Indicators relating to coverage status based on age 15.
- current_cov / future_cov: Current coverage rate versus the projected 90% coverage rate.
- curr_cc_prev / proj_cc_prev: Cervical cancer cases prevented under current coverage and under the projected 90% rate.
- curr_mort_prev / proj_mort_prev: Deaths from cervical cancer prevented under current coverage and under the projected 90% rate.
- curr_cost / proj_cost: Current cost of the vaccination program versus the projected cost at 90% coverage.
- curr_cost_prev / proj_cost_prev: Current costs prevented by reduced cervical cancer incidence versus projected costs prevented.
- possible_cancer_cases / possible_cancer_deaths: Potential total cancer cases and deaths in the absence of preventative measures.
- assumption_type: Specifies whether the data reflects current status or the goal to Attain WHO Coverage Goal.
Distribution
The data is delivered in a CSV file format (
hpv_2020s_results.csv) and contains 3520 records across 11 columns. The total file size is approximately 442.09 kB. This data is expected to be updated on an annual basis.Usage
This data product is ideally suited for:
- Public Health Planning: Evaluating national strategies for HPV vaccination implementation and distribution.
- Cost-Benefit Analysis: Determining the return on investment for high-coverage vaccination programmes by quantifying prevented costs and mortality.
- Epidemiological Modelling: Analyzing current vaccination coverage gaps and projecting future disease burden reduction based on WHO targets.
- Global Health Monitoring: Tracking country and regional progress toward cervical cancer elimination goals between 2021 and 2030.
Coverage
The data covers 176 unique countries globally, broken down by region and income group, including High income and Lower middle income countries. The time range for the projections spans ten years, specifically from 2021 through 2030. The primary demographic focus is on female cohorts eligible for vaccination by age 15.
License
Attribution 4.0 International (CC BY 4.0)
Who Can Use It
- Researchers and Academics: Utilizing robust global data to model vaccine efficacy and population-level health impact.
- International NGOs and Foundations: Targeting funding and resources based on regions showing the greatest potential mortality reduction.
- Government Health Ministries: Establishing evidence-based targets for national vaccination policy.
- Pharmaceutical and Biotech Companies: Analyzing market penetration and impact of preventative drugs and medications.
Dataset Name Suggestions
- HPV Vaccination Global Impact Projections (2021–2030)
- Cervical Cancer Mortality Prevention and Cost Estimates
- WHO 90% HPV Coverage Goal Analysis
Attributes
Original Data Source: HPV Vaccination Global Impact Projections
QUALITY